These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4015009)

  • 1. [Choice of a valve prosthesis in patients between 25 and 70 years of age].
    Gandjbakhch I; Pavie A; Jault F; Vaissier E; Bors V; Cabrol C
    Ann Cardiol Angeiol (Paris); 1985 Apr; 34(4):215-7. PubMed ID: 4015009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term antithrombotic treatment in patients with valve prostheses. Practical management and complications].
    Delahaye JP; Milon H; Ffrench P; Philippe-Bert J; Malquarti V; Saradarian W
    Ann Cardiol Angeiol (Paris); 1985 Apr; 34(4):205-11. PubMed ID: 3893303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thromboembolic accidents in patients with mechanical prostheses and heterografts].
    Ben Ismail M; Abid F; Boughzela E; Ayari M
    Ann Cardiol Angeiol (Paris); 1985 Apr; 34(4):197-203. PubMed ID: 4015006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Replacement of the mitral and aortic valves with bioprostheses. Long-term results].
    Colombo T; Cicardi C; Peronace B; Pozzi M; Gordini V; Pellegrini A
    G Ital Cardiol; 1985 Oct; 15(10):974-82. PubMed ID: 4092917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seventeen-year experience with the St. Jude medical biocor porcine bioprosthesis.
    Mykén PS
    J Heart Valve Dis; 2005 Jul; 14(4):486-92. PubMed ID: 16116875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting performance and thromboembolism after porcine xenograft cardiac valve replacement.
    Geha AS; Hammond GL; Laks H; Stansel HC; Glenn WW
    J Thorac Cardiovasc Surg; 1982 Mar; 83(3):377-84. PubMed ID: 7062749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after mitral valve replacement.
    Jamieson WR; von Lipinski O; Miyagishima RT; Burr LH; Janusz MT; Ling H; Fradet GJ; Chan F; Germann E
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1301-8. PubMed ID: 15942570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Structural changes of Hancock bioprostheses in children (author's transl)].
    Bortolotti U; Milano A; Mazzucco A; Callucci V; Valente M; Del Maschio A; Valfrè C; Thiene G
    G Ital Cardiol; 1980; 10(11):1520-5. PubMed ID: 7202899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Valvular bioprostheses and anticoagulation].
    Chambaz IC; Nendaz M
    Rev Med Suisse; 2008 Oct; 4(175):2198-202. PubMed ID: 19024573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The long term (15 years) evolution after valvular replacement with mechanical prosthesis or bioprosthesis between the age of 60 and 70 years].
    Hanania G; Michel PL; Montély JM; Warembourg H; Nardi O; Leguerrier A; Agnino A; Despins P; Legault B; Petit H; Bouraindeloup M;
    Arch Mal Coeur Vaiss; 2004 Jan; 97(1):7-14. PubMed ID: 15002704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of bioprostheses and mechanical prostheses assessed by composites of valve-related complications to 15 years after aortic valve replacement.
    Chan V; Jamieson WR; Germann E; Chan F; Miyagishima RT; Burr LH; Janusz MT; Ling H; Fradet GJ
    J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1267-73. PubMed ID: 16733156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Timing of reoperation of degenerated aortic and mitral bioprostheses].
    Vogt PR; Brunner-LaRocca HP
    Z Kardiol; 2001; 90 Suppl 6():70-4. PubMed ID: 11826825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late incidence and determinants of reoperation in patients with prosthetic heart valves.
    Ruel M; Kulik A; Rubens FD; Bédard P; Masters RG; Pipe AL; Mesana TG
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):364-70. PubMed ID: 15019662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thromboembolic and hemorrhagic complications in valve prosthesis patients].
    Ben Ismail M; Abid F; Abid A; M'Zah N; Chaouche H; Kedidi N
    Ann Cardiol Angeiol (Paris); 1983 Jun; 32(4):237-45. PubMed ID: 6614815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aortic valve replacement: choice between mechanical valves and bioprostheses.
    Silberman S; Oren A; Dotan M; Merin O; Fink D; Deeb M; Bitran D
    J Card Surg; 2008; 23(4):299-306. PubMed ID: 18462345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thromboembolic complications in patients with prostheses].
    Acar J
    Ann Cardiol Angeiol (Paris); 1985 Dec; 34(10):697-701. PubMed ID: 4091502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitral valve disease: if the mitral valve is not reparable/failed repair, is bioprosthesis suitable for replacement?
    Jamieson WR; Gudas VM; Burr LH; Janusz MT; Fradet GJ; Ling H; Germann E; Lichtenstein SV
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):104-10. PubMed ID: 19056294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
    Goldsmith I; Lip GY; Mukundan S; Rosin MD
    J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement.
    Lund O; Bland M
    J Thorac Cardiovasc Surg; 2006 Jul; 132(1):20-6. PubMed ID: 16798297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The homograft aortic valve: a 29-year, 99.3% follow up of 1,022 valve replacements.
    O'Brien MF; Harrocks S; Stafford EG; Gardner MA; Pohlner PG; Tesar PJ; Stephens F
    J Heart Valve Dis; 2001 May; 10(3):334-44; discussion 335. PubMed ID: 11380096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.